Related Experiment Videos
Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration
O Bandmann1, M G Sweeney, S E Daniel
1University Department of Clinical Neurology, Institute of Neurology, London, UK.
Abstract:
Multiple system atrophy (MSA) is a neurodegenerative disorder of unknown cause. The only case-control study conducted in MSA patients to date suggested a possible contributory genetic component in the pathogenesis of this disorder. The aim of this study was to evaluate a possible overlap between clinically or pathologically well-defined MSA and other conditions with an identified genetic defect causing spinocerebellar degeneration in humans or mutant mice strains. The spinocerebellar ataxia type 1 and 3 genes (SCA1 and SCA3) were analyzed for a pathologic expansion in 80 patients with MSA to evaluate a possible overlap between MSA and SCA1 or SCA3. Weaver mice and lurcher mice are animal models for spinocerebellar degeneration; both share pathologic features with MSA. We sequenced the H5 pore region of the human homologue of the weaver mouse gene, hiGIRK2, in all our patients. In lurcher mice, previous biochemical studies have shown a decreased intracellular response to insulin-like growth factor 1 (IGF-1) in the cerebellar cortex, and we thus investigated the possibility of an allelic association between MSA and the receptor for IGF-1. In addition, we evaluated a possible involvement of the ciliary neurotrophic factor gene (CNTF) and examined the role of HLA-A32 to clarify the conflicting data from previous studies. No changes were detected in any of the analyzed genes. Our studies strongly suggest that MSA is an autonomous syndrome distinct from identified genetic causes for spinocerebellar degeneration.
Insights
Multiple system atrophy (MSA) is a rare neurodegenerative disease. Genetic analysis of SCA1, SCA3, hiGIRK2, IGF-1 receptor, CNTF, and HLA-A32 genes in MSA patients revealed no overlap, suggesting MSA is a distinct syndrome.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Multiple system atrophy (MSA) is a neurodegenerative disorder with unknown etiology.
- Previous research suggested a potential genetic contribution to MSA pathogenesis.
- Investigating genetic links is crucial for understanding and potentially treating MSA.
Purpose of the Study:
- To investigate potential genetic overlaps between Multiple System Atrophy (MSA) and known spinocerebellar degeneration genetic defects.
- To analyze specific genes (SCA1, SCA3, hiGIRK2, IGF-1 receptor, CNTF, HLA-A32) for associations with MSA.
- To determine if MSA shares genetic causes with other spinocerebellar ataxias.
Main Methods:
- Genetic analysis of spinocerebellar ataxia type 1 (SCA1) and type 3 (SCA3) genes in 80 MSA patients.
- Sequencing of the hiGIRK2 gene (human homologue of weaver mouse gene) in all patients.
- Evaluation of allelic association with the insulin-like growth factor 1 (IGF-1) receptor.
- Assessment of the ciliary neurotrophic factor (CNTF) gene and HLA-A32.
Main Results:
- No pathologic gene expansions were detected in SCA1 or SCA3.
- Analysis of hiGIRK2, IGF-1 receptor, CNTF, and HLA-A32 showed no significant associations with MSA.
- The investigated genetic factors did not demonstrate an overlap between MSA and other spinocerebellar degenerations.
Conclusions:
- Multiple system atrophy (MSA) appears to be a distinct neurological syndrome.
- The study found no evidence linking MSA to the specific genetic defects analyzed in spinocerebellar ataxias.
- Further research into the unique pathogenesis of MSA is warranted.